CTCBIO Statistics

Total Valuation

CTCBIO has a market cap or net worth of KRW 157.56 billion. The enterprise value is 178.15 billion.

Market Cap	157.56B
Enterprise Value	178.15B

Important Dates

The next estimated earnings date is Thursday, August 21, 2025.

Earnings Date	Aug 21, 2025
Ex-Dividend Date	n/a

Share Statistics

CTCBIO has 23.91 million shares outstanding.

Current Share Class	23.91M
Shares Outstanding	23.91M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.46%
Float	15.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.08
PB Ratio	2.12
P/TBV Ratio	2.28
P/FCF Ratio	101.49
P/OCF Ratio	47.64
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 37.97, with an EV/FCF ratio of 114.76.

EV / Earnings	-41.42
EV / Sales	1.23
EV / EBITDA	37.97
EV / EBIT	n/a
EV / FCF	114.76

Financial Position

The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.44.

Current Ratio	1.20
Quick Ratio	0.63
Debt / Equity	0.44
Debt / EBITDA	6.90
Debt / FCF	20.85
Interest Coverage	-0.55

Financial Efficiency

Return on equity (ROE) is -5.53% and return on invested capital (ROIC) is -0.94%.

Return on Equity (ROE)	-5.53%
Return on Assets (ROA)	-0.67%
Return on Invested Capital (ROIC)	-0.94%
Return on Capital Employed (ROCE)	-1.86%
Revenue Per Employee	593.11M
Profits Per Employee	-17.56M
Employee Count	245
Asset Turnover	0.93
Inventory Turnover	2.88

Taxes

In the past 12 months, CTCBIO has paid 550.99 million in taxes.

Income Tax	550.99M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.43% in the last 52 weeks. The beta is 0.03, so CTCBIO's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	-19.43%
50-Day Moving Average	6,770.20
200-Day Moving Average	7,013.55
Relative Strength Index (RSI)	32.87
Average Volume (20 Days)	35,337

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CTCBIO had revenue of KRW 145.31 billion and -4.30 billion in losses. Loss per share was -179.90.

Revenue	145.31B
Gross Profit	53.23B
Operating Income	-1.67B
Pretax Income	-3.75B
Net Income	-4.30B
EBITDA	4.69B
EBIT	-1.67B
Loss Per Share	-179.90

Full Income Statement

Balance Sheet

The company has 15.67 billion in cash and 32.37 billion in debt, giving a net cash position of -16.69 billion or -698.14 per share.

Cash & Cash Equivalents	15.67B
Total Debt	32.37B
Net Cash	-16.69B
Net Cash Per Share	-698.14
Equity (Book Value)	74.16B
Book Value Per Share	2,938.41
Working Capital	11.66B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.31 billion and capital expenditures -1.75 billion, giving a free cash flow of 1.55 billion.

Operating Cash Flow	3.31B
Capital Expenditures	-1.75B
Free Cash Flow	1.55B
FCF Per Share	64.93

Full Cash Flow Statement

Margins

Gross margin is 36.63%, with operating and profit margins of -1.15% and -2.96%.

Gross Margin	36.63%
Operating Margin	-1.15%
Pretax Margin	-2.58%
Profit Margin	-2.96%
EBITDA Margin	3.23%
EBIT Margin	-1.15%
FCF Margin	1.07%

Dividends & Yields

CTCBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.73%
FCF Yield	0.99%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 22, 2013. It was a forward split with a ratio of 1.1.

Last Split Date	Apr 22, 2013
Split Type	Forward
Split Ratio	1.1

Scores

CTCBIO has an Altman Z-Score of 1.95 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.95
Piotroski F-Score	4